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ABSTRACT Outer hair cell (OHC) electromotility enables frequency selectivity and sensitivity in mammalian audition. Electro-
motility is generated by the transmembrane protein prestin and is sensitive to amphipathic compounds including salicylate, chlor-
promazine (CPZ), and trinitrophenol (TNP). Although these compounds induce observable membrane curvature changes
in erythrocytes, their effects on OHC membrane curvature are unknown. In this work, ﬂuorescence polarization microscopy
was applied to investigate the effects of salicylate, CPZ, and TNP on di-8-ANEPPS orientation in the OHC plasma membrane.
Our results demonstrate the ability of ﬂuorescence polarization microscopy to measure amphipath-induced changes in
di-8-ANEPPS orientation, consistent with nanoscale changes in membrane curvature between regularly spaced proteins con-
necting the OHC plasma membrane and cytoskeleton. Simultaneous application of oppositely charged amphipaths generally
results in no net membrane bending, consistent with predictions of the bilayer couple hypothesis; however, the application of
salicylate (10 mM), which inhibits electromotility, is not reversed by the addition of CPZ. This result supports other ﬁndings
that suggest salicylate primarily inﬂuences electromotiliy and OHC nonlinear capacitance via a direct interaction with prestin.
In contrast, we ﬁnd that CPZ and TNP inﬂuence the voltage sensitivity of prestin via membrane bending, demonstrating the
mechanosensitivity of this unique membrane motor protein.INTRODUCTION
Outer hair cells (OHCs) of the mammalian cochlea respond
to changes in transmembrane potential via whole-cell, axial
deformations (1–3), a process referred to as electromotility.
Electromotility contributes to the sensitivity and frequency
selectivity of mammalian hearing (4–6) and is often character-
ized by its accepted electrical signature, a measurable, volt-
age-dependent nonlinear capacitance (NLC) (7). This NLC
represents charge movement within the OHC membrane, sim-
ilar to an ion channel gating current, that is tightly coupled to
voltage-driven length changes (8–10). The dependence of this
capacitance on transmembrane potential follows a bell-shaped
curve, the peak of which occurs at the voltage where the high-
est electromotile gain is realized. Several perturbations are
known to affect the NLC operating range, including membrane
tension (11); membrane cholesterol concentration (12,13); and
exposure to the amphipathic compounds salicylate (14,15),
chlorpromazine (CPZ) (16,17), and trinitrophenol (TNP)
(17). Each of these amphipath-induced perturbations results
in a depolarizing shift in NLC voltage dependence; however,
in the case of 10 mM salicylate, NLC and electromotility are
almost entirely abolished (14,15,18). The biophysical mecha-
nism(s) responsible for these effects are unknown, but salicy-
late and CPZ have been reported to affect lipid lateral mobility
(19) and OHC plasma membrane mechanical properties
(20,21), and these compounds have corresponding effects on
two physiological measures of hearing: the compound action
potential and distortion product otoacoustic emissions (22).
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mechanics were originally documented in classic studies
conducted in red blood cells (RBCs), which formed the basis
for the bilayer couple hypothesis of membrane shape transi-
tions (23–25). Compounds that are negatively charged, such
as salicylate and TNP, partition preferentially into the outer
bilayer leaflet, generating leaflet expansion and outward
membrane bending. Positively charged amphipaths, includ-
ing CPZ, partition into the negatively charged inner leaflet
and generate inward membrane bending. The manifestation
of this preferential partitioning is demonstrated by images
of RBCs that are crenulated when exposed to salicylate or
TNP or cupped when exposed to CPZ (26). Quantitative
models based on area-difference elasticity (27) were devel-
oped and later used to explain a range of RBC shape transi-
tions (28–30), further refining the bilayer couple hypothesis.
The molecular basis for OHC electromotility and NLC is
the transmembrane protein prestin (6,31). Prestin is a member
of the SLC26 superfamily of anion transporters (32) and is
expressed highly and selectively in the plasma membrane
of OHCs (33). Models for the role of a motor protein in elec-
tromotility predict that the protein undergoes conformational
changes within the plane of the membrane (34–37) or in
a manner that coincides with or induces membrane bending
(38). The models purport that the concerted action of many
densely packed protein molecules translates to whole-cell
axial deformations.
Evidence that the plasma membrane can act as an
allosteric modulator of transmembrane protein function is
mounting (39), and membrane perturbations that affect pres-
tin function such as modulation of membrane cholesterol
doi: 10.1016/j.bpj.2008.09.016
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are likely linked to alterations of prestin-membrane interac-
tions. Bilayer couple effects have been well characterized
in mechanosensitive ion channels (40,41), and membrane
curvature stress has been shown to affect the function of
many proteins, including rhodopsin (42) and the Ca2þ-acti-
vated BK channel (43,44). Additionally, membrane curva-
ture has been predicted (45) and demonstrated (46) to affect
protein oligomerization, a finding made more relevant to the
auditory field following the demonstration of prestin self-
association (47–50). Changes in curvature can result from
alterations in the membrane lateral pressure profile, which is
highly dependent on membrane composition and influences
the work associated with protein conformational changes
(51–55), such as those predicted for prestin. Lateral pressure
profile effects are more pronounced for proteins with depth-
dependent cross sectional areas. Interestingly, a recent elec-
tron microscopy study indicates that prestin is a bullet-shaped
molecule with a greater cross sectional area in the mem-
brane’s inner leaflet (56).
Given the effects of amphiphiles on RBC shape and the
apparent mechanosensitivity of prestin, it is reasonable to
postulate that salicylate, CPZ, and TNP exert their influence
on prestin function and electromotility through modulation
of membrane curvature. However, understanding these ef-
fects requires consideration of the unique architecture and
mechanics of the OHC lateral wall, which contains three
structures: the plasma membrane, a cortical cytoskeleton,
and the subsurface cisternae. Specifically, the OHC cortical
cytoskeleton is made up of circumferentially wound actin fil-
aments cross-linked by spectrin filaments oriented along the
longitudinal axis of the cell (57,58). An additional structure
of unknown molecular identity, visible in electron micro-
graphs, connects the plasma membrane to the cytoskeleton
at fairly regularly spaced intervals both in the axial and cir-
cumferential direction. This structure, referred to as the pillar
protein, has been postulated to provide necessary anchor
points that allow the OHC plasma membrane to bend in
a consistent and regular manner (38). The cortical cytoskel-
eton and a positive intracellular (turgor) pressure together
help maintain the cylindrical shape of the OHC and greatly
influence overall cell mechanics (5,57,59). Although previ-
ous models have predicted OHC plasma membrane bending
between pillar attachment sites, it remains controversial
whether the membrane is free to deform in this manner or in-
stead remains tightly coupled to the underlying cytoskeleton,
as discussed in recent reviews (4,7).
To investigate the hypothesis that amphipathic compounds
induce OHC plasma membrane bending, we employed fluo-
rescence polarization microscopy (FPM), a quantitative
microscopy technique capable of measuring fluorophore
orientation with respect to the plane of the membrane. We re-
cently developed FPM for use in the quasicylindrical OHC
and demonstrated its ability to measure the orientation of
pyridinium, 4-[2-[6-(dioctylamino)-2-naphthalenyl]ethenyl]-1-(3-sulfopropyl) (di-8-ANEPPS) in the plasma membrane
(60). This novel implementation of FPM required a reformu-
lation of the original theory developed by Axelrod for use in
sphered RBCs (61). Di-8-ANEPPS is a voltage-dependent
probe designed to partition into the membrane and align with
the polar and nonpolar regions of adjacent lipids (62,63). In
previous studies of di-8-ANEPPS orientation in the OHC,
we found that its absorption transition dipole moment main-
tains an orientation of ~27 with respect to the plane of the
membrane, corresponding to an emission transition dipole
moment orientation of ~89 (60). Because of this orientation
parallel to the acyl chains of the membrane lipid component,
we predicted that di-8-ANEPPS would be a sensitive indica-
tor of changes in membrane curvature.
In this work, FPM is employed to investigate the effects
of curvature-inducing amphipaths on the orientation of di-
8-ANEPPS with respect to the OHC plasma membrane. A
model of OHC plasma membrane bending is then invoked
to explain observed orientation shifts. Measured changes in
di-8-ANEPPS orientation are consistent with changes in
nanoscale membrane curvature and suggest that CPZ and
TNP exert their effects on prestin through changes in mem-
brane curvature. Conversely, salicylate’s competition with
intracellular anions necessary for prestin function (64,65)
may dominate any membrane-mediated effects and explain
salicylate’s ability to diminish NLC rather than simply shift
the voltage dependence of the NLC.
MATERIALS AND METHODS
Outer hair cell isolation, loading, and treatment
OHCs were isolated from female albino guinea pigs weighing 150–225 g, as
described previously (60). Animals were anesthetized with halothane before
decapitation. Temporal bones were placed in standard extracellular bathing
solution (140 mM NaCl, 5 mM KCl, 10 mM HEPES, 10 mM glucose, 1 mM
MgCl2, 2 mM CaCl2, ~290–300 mOsm, pH 7.3), and the otic capsule was
removed up to the second cochlear turn. The entire temporal bone was
then placed in extracellular solution containing 150 mM di-8-ANEPPS
and incubated at room temperature for 20 min. Following dye loading,
OHC isolation was carried out in one of seven amphipath-containing solu-
tions. Cells were exposed to either 0.5 mM salicylate, 10 mM salicylate,
0.1 mM CPZ, 0.1 mM TNP, 0.5 mM salicylate and 0.1 mM CPZ simulta-
neously, 10 mM salicylate and 0.1 mM CPZ simultaneously, or 0.1 mM
CPZ and 0.1 mM TNP simultaneously. All solutions were adjusted to pH
7.3 and ~290–300 mOsm (with glucose). Following suspension in the am-
phipath-containing solutions, FPM images were collected after 10 min but
within 1.5 h after amphipath introduction.
Outer hair cell ﬂuorescence polarization
microscopy
FPM experiments were implemented as described previously using a Zeiss
Axiovert 200M fluorescence microscope, a Plan-Apochromat 63, NA 1.4
objective lens, and a cooled charged-coupled device camera (Axiocam)
(Carl Zeiss Microimaging, Thornwood, NY) (60). Briefly, OHCs were se-
lected for imaging using standard OHC selection criteria. Cells maintained
a uniform cylindrical shape, had a nucleus showing little axial migration,
and exhibited minimal internal Brownian motion. Cells fitting these criteria
were brought into vertical alignment with the optical axis, and two FPM
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images were obtained. The first image uses parallel excitation and emission
polarizations, and the second preserves the excitation polarization direction
but uses a crossed emission polarizer. Intensity measurements from three re-
gions of interest (Fig. 1 a) were obtained for FPM analysis and optimization.
Before imaging each day, necessary calibration factors were obtained and
remained within the range previously published (60).
From intensity measurements, five ratios are calculated (Eq. 1). Here the
subscript denotes the orientation of the emission polarizer, and the super-
script denotes the measurement region. The measurement taken at the left
side of the cell (B0) is averaged with the intensity at point B to exploit the
















These ratios can also be theoretically predicted, as described previously
(60), and optimization between the measured and predicted values depends
upon the orientation of the fluorophore, defined as q, and the percentage of
molecules that maintain this orientation, the oriented fraction (OF). Optimi-
zation is carried out using MATLAB’s (The Mathworks, Natick, MA) built-
in genetic algorithm toolbox, as described previously (60). The value q
represents the orientation of the absorption transition dipole moment of
di-8-ANEPPS with respect to the plane of the membrane brought into align-
ment with the optical axis X3 (Fig. 1 b).
For all treatment groups, the resulting q, OF, and fitting function value
(ffval) are presented. In the course of experimentation, we found the ratio
FBt=F
A
k to be an excellent indicator of di-8-ANEPPS internalization, a sign
of degraded OHC health. The fluorescence from the center region A should
always be low compared to the membrane region B, particularly with a per-
pendicular analyzer. If this ratio is less than or equal to one for any cell, di-
8-ANEPPS has been internalized, and the cell is removed from the final
cell pool to prevent confounding of FPM intensity measurements.
FPM was used to investigate the orientation of di-8-ANEPPS in OHCs
treated with various amphipathic compounds known to alter membrane cur-
vature. OHCs were exposed to either a positively charged, inward bending
amphipath (CPZ) or a negatively charged, outward bending amphipath
(salicylate, TNP) for individual treatments. For dual treatments, CPZ was
paired with one of the negatively charged amphipaths to neutralize mem-
brane bending. Amphipath treatments of OHCs did not result in visible mor-
phological changes such as those seen in RBCs (Fig. 2), consistent with
earlier reports (17,19–22). It has previously been documented that OHCs un-
dergo a shortening when exposed to CPZ and TNP (17); however, we did
not assess length changes as OHCs were visualized only after treatment
with amphipathic compounds.
A total of 83 OHCs was analyzed for this study. Control results from a pre-
viously published study were reinterpreted using the restriction described
above for FBt=F
A
k , allowing comparison to new data (60). All experimental
conditions for treatment groups are consistent with those used to obtain the
control cell pool allowing this comparison. Two methods were used to de-
termine q and OF. In the first, referred to as grouped, the average ratio values
for each treatment case were used for optimization. In the second, referred to
as individual, the FPM optimization algorithm is carried out for each indi-
vidual cell’s ratio values, and the resulting q and OF values are averaged
to represent the entire cell pool. A comparison of these results demonstrates
consistency between the methods (Table 1); however, we will restrict our
discussion to the individual averaged orientations since they allow statistical
comparison between treatment groups and control.
Statistical analysis
Statistical analysis was conducted using a one-factor (amphipath treatment)
analysis of variance for all groups. This analysis was carried out for both
q and OF individually. If a parameter’s F-test was significant (p < 0.05),
a Tukey’s post hoc analysis was completed. The p-values subsequently
referred to were generated from these post hoc analyses.
RESULTS
The cells shown in Fig. 2 are representative of all cells from
each treatment group throughout the course of the study.
Though alterations in OHC plasma membrane architecture
were not readily apparent from FPM images, changes in
OHC FPM ratios were evident between treatment groups
(Table 1).
Outer hair cell treatment with CPZ and TNP
In untreated OHCs, the orientation of di-8-ANEPPS is
29.9 5 8.6 with respect to the plane of the membrane.
In cells treated with 0.1 mM TNP, di-8-ANEPPS orients at
13.3 5 5.6 corresponding to a significant shift of 16.6
(p < 0.001). In cells treated with 0.1 mM CPZ, di-8-
ANEPPS orients at 18.35 5.1, shifted 11.6 from the con-
trol orientation (p< 0.05) (Fig. 3 and Table 1). Interestingly,
in cells treated simultaneously with CPZ and TNP (both at
0.1 mM), di-8-ANEPPS orients at 23.3 5 6.5, which is
not statistically significantly different from the control orien-
tation. This result suggests that CPZ and TNP are capable of
attenuating each other’s bending effects (Fig. 4 and Table 1).
FIGURE 1 (a) Orientation of an OHC in the fixed, micro-
scope frame of reference denoted by the X coordinate system.
The regions A, B, and B0 are the FPM measurement regions.
The orientation of the emission polarizer is defined as parallel
when its transmission axis is aligned along the X3 axis and de-
fined as perpendicular when its transmission axis is aligned
along the X2 axis. (b) Schematic representing the orientation
of di-8-ANEPPS (shown in black) in the membrane. The angle
q defines fluorophore orientation with respect to the X3 axis, or
the plane of the uncurved membrane.
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No significant differences are reported in the OFs corre-
sponding to each treatment group (Table 1).
Outer hair cell treatment with salicylate
Two different concentrations of salicylate were investigated
in both individual and dual treatments. Among all amphi-
paths studied, salicylate alone has the ability to almost com-
pletely block NLC and electromotility at 10 mM, but this
block is reversible (14,15,18). At lower concentrations
(0.5 mM), salicylate attenuates NLC and electromotility (15)
while inducing a similar depolarizing shift in the operating
range, as reported with CPZ and TNP (17). Thus, we inves-
tigated salicylate’s effects on di-8-ANEPPS orientation at
both 10 mM and 0.5 mM.
Di-8-ANEPPS maintained an average orientation of
21.0 5 8.5 with respect to the plane of the membrane in
OHCs treated with 0.5 mM salicylate. This reduction in ori-
entation angle from the control group is not statistically sig-
nificant (p ¼ 0.11). Treatment with 10 mM salicylate
reduces the orientation angle further to 18.5 5 6.9 (p <
0.05) (Fig. 3 and Table 1). Dual treatment with 0.5 mM
salicylate and 0.1 mM CPZ results in a di-8-ANEPPS orien-
tation of 24.05 9.2, statistically similar to the control ori-
entation (p ¼ 0.73). However, dual treatment with 10 mM
salicylate and 0.1 mM CPZ results in a di-8-ANEPPS orien-
tation of 16.0 5 7.7 (p < 0.005) (Fig. 4 and Table 1). No
significant shifts in the OF are observed for salicylate treat-
ment cases (Table 1).
DISCUSSION
We have demonstrated the ability of FPM to detect shifts in
the orientation of di-8-ANEPPS in OHCs exposed to mem-
brane curvature-inducing amphipaths. Di-8-ANEPPS was
chosen for these experiments for two reasons. First, this fluo-
rophore has been used successfully in numerous quantitative
fluorescence microscopy studies in the OHC (19,60,66–68).
These studies demonstrated that di-8-ANEPPS partitions ef-
fectively and selectively into the OHC plasma membrane
and is not significantly internalized in healthy, excised cells
during the time course of FPM experimentation. Second,
di-8-ANEPPS was chosen for its preferred orientation in the
plasma membrane. Predictions based on chemical structure
and our previous measurement of di-8-ANEPPS orientation
in untreated OHCs (60) indicate the molecule partitions with
the long axis of its chromophore parallel to the long axis of
adjacent lipids (Fig. 1). As the molecule will remain in the
completely extended trans state during experimentation (62),
the probe should behave as a rigid indicator of membrane cur-
vature. Additionally, because the structure of the fluorophore
mimics that of its lipid counterparts, minimal perturbations
to the membrane environment are expected to result from its
incorporation into the plasma membrane (62).
OHCs labeled with di-8-ANEPPS were treated with three
different amphipathic compounds in a series of individual
and dual treatments to test for bilayer couple effects. None
of these treatments resulted in visible morphological changes
in OHC plasma membrane shape; however, all individual
FIGURE 2 OHC FPM images. (a–c) These sample images from a cell treated with 10 mM salicylate are representative of images obtained from all amphi-
path treatment groups. As shown here, no visible, morphological changes were seen in OHCs treated with amphipaths. (a) Transmitted light image. Scale bar is
10 mm. (b) FPM image obtained with parallel excitation and emission polarizers. (c) FPM image obtained with crossed excitation and emission polarizers. (d–j)
Transmitted light images of RBCs from each amphipath treatment group. These images are included to demonstrate that RBCs included in OHC treatment
dishes underwent shape transitions as expected. Images are of RBCs treated with (d) 0.5 mM salicylate, (e) 10 mM salicylate, (f) 0.1 mM CPZ, (g) 0.1
mM TNP, (h) 0.5 mM salicylate and 0.1 mM CPZ simultaneously, (i) 10 mM salicylate and 0.1 mM CPZ simultaneously, and (j) 0.1 mM TNP and
0.1 mM CPZ simultaneously.
Biophysical Journal 96(2) 510–520
Amphipaths and OHC Membrane Curvature 513
TABLE 1 FPM optimization results for all treatment groups
Control (n ¼ 13) 0.1 mM TNP (n ¼ 8) 0.1 mM CPZ (n ¼ 10) 0.1 mM TNP þ 0.1 mM CPZ (n ¼ 12)
Ratio Experiment Theory Experiment Theory Experiment Theory Experiment Theory
FBt=F
B
k 1.445 0.19 1.46 1.175 0.09 1.16 1.225 0.08 1.21 1.285 0.16 1.34
FAk=F
B
k 1.025 0.07 0.88 1.025 0.04 0.86 1.025 0.02 0.89 1.045 0.04 0.89
FAt=F
B
t 0.635 0.11 0.69 0.725 0.09 0.84 0.745 0.06 0.84 0.665 0.11 0.76
FAt=F
B
k 0.895 0.12 1.01 0.835 0.07 0.97 0.905 0.03 1.02 0.845 0.09 1.02
FBt=F
A
k 1.415 0.20 1.64 1.145 0.09 1.35 1.205 0.06 1.37 1.235 0.16 1.51
qgrouped 29.7
 qgrouped 14.0 qgrouped 19.2 qgrouped 26.1
OFgrouped 46.0% OFgrouped 69.0% OFgrouped 52.3% OFgrouped 45.5%
ffval 0.62 ffval 1.77 ffval 1.96 ffval 1.69
qindividual 29.9
 5 8.6 qindividual 14.0 5 5.7** qindividual 18.3 5 5.1* qindividual 23.0 5 6.3





0.5 mM Salicylate þ 0.1 mM CPZ
(n ¼ 6)
10 mM Salicylate þ 0.1 mM CPZ
(n ¼ 10)
Ratio Experiment Theory Experiment Theory Experiment Theory Experiment Theory
FBt=F
B
k 1.265 0.12 1.28 1.215 0.09 1.21 1.505 0.23 1.47 1.165 0.05 1.17
FAk=F
B
k 1.045 0.04 0.86 1.035 0.04 0.87 1.035 0.06 0.81 1.055 0.03 0.91
FAt=F
B
t 0.675 0.05 0.76 0.725 0.05 0.82 0.565 0.13 0.62 0.795 0.03 0.89
FAt=F
B
k 0.855 0.06 0.98 0.875 0.06 0.99 0.815 0.06 0.92 0.925 0.05 1.04
FBt=F
A
k 1.225 0.09 1.49 1.185 0.07 1.39 1.455 0.26 1.80 1.115 0.04 1.29
qgrouped 21.6
 qgrouped 18.5 qgrouped 25.9 qgrouped 15.5
OFgrouped 57.0% OFgrouped 57.8% OFgrouped 62.2% OFgrouped 53.71%
ffval 2.03 ffval 1.75 ffval 1.34 ffval 2.11
qindividual 21.0
 5 8.5 qindividual 18.5 5 6.9* qindividual 24.0 5 9.2 qindividual 16.0 5 7.7**
OFindividual 60.85 17.6% OFindividual 58.9%5 18.8% OFindividual 67.7%5 13.3% OFindividual 55.7%5 23.9%
Theoretical FPM ratio values were obtained using average ratio values for each treatment group.
*p < 0.05.
**p < 0.005.
514 Greeson and Raphaeltreatments shifted di-8-ANEPPS orientation as measured by
changes in q, and, with the exception of 0.5 mM salicylate,
these shifts were statistically significant (Fig. 3 and Table
1). Treatments of OHCs with two amphipaths simultaneously
were also conducted. When 10 mM salicylate was simulta-
neously applied with 0.1 mM CPZ, the orientation of di-
8-ANEPPS remained significantly shifted. However, when
either 0.1 mM TNP and 0.1 mM CPZ or 0.5 mM salicylate
and 0.1 mM CPZ were applied together, the measured orien-
tation of di-8-ANEPPS was statistically equivalent to that in
untreated cells. These latter results suggest that CPZ and
TNP qualitatively follow the predictions of the bilayer couple
hypothesis in the OHC. By partitioning into opposing leaflets,
CPZ and TNP diminish the differential area expansion that
drives curvature changes when the compounds are applied in-
dividually. CPZ also seems capable of partially attenuating
salicylate’s effect on di-8-ANEPPS orientation at low salicy-
late concentrations, though the differences between the indi-
vidual and dual treatment are not statistically significantly
different according to rigorous statistical analyses.
Membrane curvature model of di-8-ANEPPS
reorientation
The data presented here document the reorientation of the
membrane probe di-8-ANEPPS following treatment of OHCs
Biophysical Journal 96(2) 510–520with salicylate, CPZ, and TNP. These amphipathic com-
pounds cause curvature-induced shape transformations in
RBCs; however, despite theoretical predictions (17,19,38),
experiments had not previously determined whether such
membrane curvature changes are manifested in OHCs. Before
FIGURE 3 Di-8-ANEPPS orientations for cells treated with CPZ and
TNP. Box ends designate the upper and lower quartiles of the data. Medians
are shown as lines through each box and whiskers indicate the extent of the
data up to 1.5 times the standard deviation. Averages and standard devia-
tions for each group are presented in Table 1 (*p < 0.05, **p < 0.005).
answering this question, we first examine potential mecha-
nisms for the induced shifts in di-8-ANEPPS orientation.
Since both di-8-ANEPPS and the amphipathic compounds
used partition into the plasma membrane, the potential exists
for molecular interactions that may confound orientation mea-
surements. We rule out this possibility as follows. First, if
CPZ and TNP only exerted their effects on di-8-ANEPPS ori-
entation through a molecular or electrostatic interaction, the
simultaneous application of the two compounds would not re-
sult in a return to the control orientation. Instead, the measured
orientation of di-8-ANEPPS would be a weighted average of
the two orientations found when cells are treated with each
compound individually.
Additionally, we have investigated the effects of both 10
and 50 mM salicylate on the orientation of di-8-ANEPPS in
1-stearoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (SOPC)
giant unilamellar vesicles (69) using methods presented pre-
viously (70). In these studies, even at 50 mM, salicylate only
induced a di-8-ANEPPS orientation shift of ~2. Although
this may indicate a small amount of interaction between salic-
ylate and di-8-ANEPPS, it cannot account for the much larger
shifts in di-8-ANEPPS orientation seen in OHCs. This is also
an important finding, as the lack of di-8-ANEPPS orientation
shift in amphipath-treated giant unilamellar vesicles confirms
the necessity of leaflet charge asymmetry in driving pref-
erential partitioning of amphipathic compounds. In a pure
SOPC membrane without a negatively charged inner leaflet,
salicylate would partition more easily into both leaflets. In
the absence of preferential partitioning, no changes in mem-
brane curvature would be expected, though the mechanical
properties of the membrane would still be affected as shown
previously (71).
FIGURE 4 Di-8-ANEPPS orientations for cells treated with CPZ and
TNP. As with Fig. 2, box ends designate the upper and lower quartiles of
the data. Medians are shown as lines through each box, and whiskers indi-
cate the extent of the data to 1.5 times the standard deviation. In the case of
simultaneous treatment with 0.5 mM salicylate and CPZ, the tightening of
the distribution is explained by the presence of two outliers. Averages and
standard deviations for each group are presented in Table 1 (**p < 0.005).
Amphipaths and OHC Membrane CurvatureIt could also be argued that the reversal of di-8-ANEPPS
orientation shifts in the dual treatment cases results from a di-
rect interaction between the positively and negatively charged
amphipaths in solution. This is unlikely, however, as this
interaction would occur rather quickly in solution and would
result in the formation of a readily visible precipitate, some-
thing not seen during experimentation. We are thus led to
conclude that the measured changes in di-8-ANEPPS orienta-
tion reflect changes in OHC plasma membrane curvature.
The membrane curvature model described here, similar to
those that have come before it (17,19,38), presumes that the
membrane is ‘‘pinned’’ by cytoskeletal pillar proteins but is
capable of deformation in the regions between these anchor
points (Fig. 5). We first determined a two-dimensional rela-
tionship between pillar spacing and deformation. In Fig. 5,
the plane of the membrane is represented by the dark gray
line, and oriented di-8-ANEPPS molecules are shown as
light gray arrows. The transition from Fig. 5, a to b, indicates
the allowed deformation of the membrane. On the deformed
arc, the orientation at point B represents the average orienta-
tion for all di-8-ANEPPS molecules, assuming an even
distribution along the length of the curve. We rely on this as-
sumption for simplicity, recognizing that our model does not
account for complex curvatures that may arise at the intersec-
tion of the pillar and the plasma membrane. It is conceivable,
however, that di-8-ANEPPS avoids these regions due to
crowding or hydrophobic mismatch at the protein interface
and instead favors the membrane arc as modeled.
If we assume that the measured orientation shifts corre-
spond to the ensemble orientation represented by point B
along a region of curved OHC membrane, we can calculate
the corresponding angle that subtends the membrane arc (d)
(Fig. 5 b). Values for d that correspond to measured orienta-
tion shifts (Dq) are shown in Table 2. A simple geometric
equation relates d, the arc length (s), the radius of curvature









Using Eq. 2, we can plot the relationship between these
parameters over a range of relevant values. The spacing be-
tween pillar proteins is estimated to range from 20 to 80 nm
(58), and our own observations using electron tomography
(W. J. Triffo, R. M. Raphael, and M. Auer, unpublished)
suggest an axial pillar spacing of ~36 nm which agrees
with previous measurements (72). Reasonable bounds for
the radius of curvature are 10–100 nm. In Fig. 5 c, we show
the relationship between these parameters and our measured
shifts in di-8-ANEPPS orientation. Using these results, rc
can be calculated for various values of p.
Assuming a pillar spacing of 36 nm, several parameters
relating to the predicted change in membrane curvature can
Biophysical Journal 96(2) 510–520
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now be estimated (Table 2). These parameters include rc, s,
the height of the curved region of membrane in relation to
a flat bilayer (h), and the surface area of the distended mem-
brane region (SAtile). We assume the OHC pillars maintain
the same spacing circumferentially as axially. Extending
the two-dimensional membrane bending shown in Fig. 5
into the third dimension, we allow only one radius of curva-
ture approximating the membrane region spanning four pil-
lars as a section of a cylinder (Fig. 6 b).
FPM experiments on di-8-ANEPPS-labeled, untreated
OHCs predict the absorption transition dipole moment of
di-8-ANEPPS to be oriented at ~30. From previous studies,
the angle between the absorption and emission transition di-
pole moments is known and is 62 (60), indicating the emis-
sion transition dipole moment orients at ~92. This result
suggests that there is very little or no initial curvature in
the OHC membrane in isolated unclamped cells, a suggestion
consistent with previous findings where cell shortening was
seen following OHC treatment with either CPZ or TNP (17).
If the OHC plasma membrane was initially curved, treatment
with opposing amphipaths would result in length changes in
opposite directions. Note, however, that the absence of initial
curvature does not imply the absence of bending energy as
the spontaneous curvature of the OHC plasma membrane
is unknown.
With no initial curvature, the area of membrane spanning
four pillar pinning points would simply be the area of a
square with sides of 36 nm. Using this assumption, we can
TABLE 2 d and rc values corresponding to orientation shifts seen for treatment with 10 mM salicylate, 0.1 mM TNP, 0.1 mM CPZ,
and 10 mM salicylate plus 0.1 mM CPZ
Treatment Dq d rc (nm) s (nmrad) h (nm) SAtile (nm2) D SAtile (nm2)
10 mM salicylate 11.4 45.6 46.4 36.9 3.6 1328.4 32.4
0.1 mM TNP 16.6 66.4 32.9 38.1 5.4 1371.6 75.6
0.1 mM CPZ 11.6 46.4 45.7 37.0 3.7 1332.0 36.0
10 mM salicylate þ 0.1 mM CPZ 13.9 55.6 38.6 37.5 4.5 1350.0 54.0
FIGURE 5 Graphical depiction of
two-dimensional membrane deforma-
tion. (a) Membrane segment before de-
formation. The open black rectangles at
either end represent the lateral wall pillar
protein. Gray arrows indicate the approx-
imate orientation of the emission transi-
tion dipole moment of di-8-ANEPPS.
We assume for simplicity that di-8-
ANEPPS molecules are evenly spaced
along the membrane segment of arc
length s. (b) Membrane segment follow-
ing deformation. The average orientation
of di-8-ANEPPS along the curved region
of membrane is equivalent to the orienta-
tion of a single fluorophore at point B.
The angle subtended by the segment of
membrane is d, and the corresponding
radius of curvature is rc. In this model
we do not account for complex curva-
tures surely present at the intersection of
the plasma membrane and each pillar pro-
tein. The new height of the membrane
with respect to its initial location is desig-
nated as h. (c) Relationship between
pillar spacing (p), radius of curvature
(rc), and the solid angle (d). Curves are
plotted over the relevant ranges of these
parameters asdefined by the literatureand
for the subtended angles corresponding
to our measured shifts in di-8-ANEPPS
orientation.
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FIGURE 6 Graphical depiction of changes in
membrane curvature at the cellular level. We assume
constant pillar spacing in both the axial and circum-
ferential directions. (a) OHC showing a close-up of
the curved plasma membrane. Cytoskeletal pillar
proteins act as anchors. (b) To simplify our curvature
model, we assume that membrane bending occurs
only at one radius of curvature in planes correspond-
ing to the image plane. This image depicts a top-
down view of the OHC membrane.
Amphipaths and OHC Membrane Curvature 517determine the fractional area change when the membrane
bends (DSAtile). The predicted changes in membrane height
range from 3.6 to 5.4 nm, indicating subtle membrane
bending, and the corresponding changes in membrane arc
surface area range from 32 to 76 nm2, a 2%–6% increase
(Table 2). The curvature model demonstrated here reflects
the lack of visible morphological OHC changes in response
to amphipath partitioning, as nanoscale changes in membrane
curvature would not be visible through light microscopy
alone.
The relationship between observed shifts in di-8-ANEPPS
orientation and predicted changes in OHC membrane curva-
ture is further supported by the results from the simultaneous
TNP and CPZ treatment. If each of these compounds’ pri-
mary effect on OHCs is manifested as curvature changes
induced via preferential partitioning, then simultaneous ap-
plication at appropriate concentrations should result in no net
membrane bending and therefore no shift in di-8-ANEPPS
orientation. The orientation of di-8-ANEPPS in cells treated
simultaneously with CPZ and TNP is 23.0, a value that
demonstrates CPZ and TNP’s ability to attenuate each
other’s membrane-bending effects. The detectable, but insig-
nificant orientation shift may arise from the use of CPZ and
TNP concentrations that do not induce precisely equivalent
membrane bending, a hypothesis that is supported by results
from individual treatments. TNP induces a shift of 14,
whereas CPZ alters di-8-ANEPPS orientation by only 8.2.
Additionally, CPZ’s inability to induce membrane bending
as significant as TNPs may arise from the OHCs positive in-
tracellular turgor pressure: inward membrane bending may
be partially counteracted by this force.
Results from dual applications using salicylate are less
straightforward. Treatment of OHCs with 10 mM salicylate
and 0.1 mM CPZ simultaneously does not return di-8-
ANEPPS to an orientation commensurate with untreated
cells. Although salicylate has been shown to dramatically re-
duce the bending stiffness of synthetic membranes (71), sa-
licylate also acts as a competitive antagonist to intracellular
anions necessary for prestin function (64,65). As such, we
consider two potential mechanisms for salicylate’s effect
on di-8-ANEPPS orientation: an effect mediated throughmembrane curvature and an effect mediated through interac-
tion with prestin. Notably, at 0.5 mM, consistent trends in
the data suggest that salicylate’s effect on di-8-ANEPPS ori-
entation may be partially attenuated by the simultaneous
application of CPZ. Perhaps at lower concentrations where
salicylate only slightly reduces prestin function, salicylate’s
membrane-mediated effects that shift the voltage sensitivity
of the NLC are measurable. At the higher concentration of
10 mM, a sufficient amount of salicylate’s charged species
is present in the cytosol to either bind to or allosterically
modulate prestin, resulting in greatly diminished function
that masks the membrane-bending effects as a result of the
reduction of the NLC curve.
Salicylate-prestin interactions
Our surprising observation that the orientation of di-8-
ANEPPS remains shifted even after the application of CPZ
to salicylate-treated OHCs suggests that in prestin’s inhibited
state, prestin-membrane interactions may significantly alter
the material properties of the OHC bilayer. Perhaps the salic-
ylate-induced conformational change in prestin elicits mem-
brane bending? Alternatively, it is possible that the reversal
of salicylate’s bending effects at 10 mM may require a higher
concentration of CPZ. However, in the simultaneous treat-
ment, CPZ does not appear to even partially reverse the
salicylate-induced di-8-ANEPPS orientation shift (Fig. 4).
This result, combined with the evidence for an interaction
between salicylate and prestin (64,65), advocates a more
complicated mechanism for salicylate-induced prestin inhi-
bition that would not be counteracted by higher concentra-
tions of CPZ.
Implications for models of electromotility
Although our results provide evidence that the OHC plasma
membrane is capable of bending in a manner originally
predicted by the membrane-bending model of electromotil-
ity (38), they call into question some of the original as-
sumptions of this model. The bending model assumed
that units of OHC membrane between pillars were initially
curved at the cell’s holding potential. The observed shifts in
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di-8-ANEPPS orientation following treatment with oppos-
ing amphipaths imply zero initial curvature, consistent
with recent results demonstrating a shortening of OHCs fol-
lowing treatment with either CPZ or TNP (17). Although
the initial curvature was mathematically introduced as an ar-
bitrary parameter in the bending model (38), it is difficult to
picture how electrically induced curvature deformations can
both shorten and elongate the cell from a flat state without
introducing additional complexity. Additionally, as recently
discussed (17), evidence indicates that treatment with mem-
brane altering agents does not necessarily disrupt electro-
motile force generation and that treatment with oppositely
charged amphipaths shifts the voltage dependence of
OHC NLC in the same direction. A more sophisticated
model is needed to describe the relation between curvature
elastic energy, prestin function, and the transmission of
forces to the cytoskeleton.
A particular focus of future modeling efforts could dis-
tinguish the curvature sensitivity of prestin function from
cellular motility and force generation. For example, if con-
formational changes of the motor protein drive or coincide
with changes in membrane bending, treatment with agents
known to affect membrane bending could conceivably shift
the voltage sensitivity of prestin by inducing conformational
changes without affecting the capacity for force generation.
Under this picture, the bending of the OHC plasma mem-
brane induced by CPZ or TNP could force more prestin mol-
ecules into the extended state, shifting the NLC curve in the
positive direction. The capacity for force generation would
remain intact, and the only change would be the relative dis-
tribution of motor proteins among possible states at the cell’s
normal holding potential.
CONCLUSION
The work presented here demonstrates the ability of FPM to
measure subtle changes in membrane curvature. Our results
indicate that CPZ and TNP are capable of inducing nanoscale
curvature changes in the OHC plasma membrane that corre-
late with experimentally observed depolarizing shifts in NLC
(15–17). For treatment with CPZ and TNP, these curvature
changes are qualitatively explained by the predictions of the
bilayer couple theory and are likely the mechanism by which
these compounds alter the voltage dependence of prestin
function (Fig. 7). This conclusion is consistent with previous
suggestions that CPZ and TNP affect prestin function (17) and
consequently cochlear amplification (73) in a membrane-
mediated manner. Prestin’s mechanosensitivity is intricately
connected to alterations in bilayer properties since these
changes affect the thermodynamic work required for confor-
mational transitions and the generation of electromotile
forces. Thus, the curvature, composition, and overall mechan-
ics of the OHC plasma membrane must be held at a precise
equilibrium point to optimize electromotility at physiological
receptor potentials.
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